Original Research
Published on 15 Jun 2023
Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells
in Nanobiotechnology
- 3,921 views
- 3 citations